A Pilot Surrogate End Point Biomarker Trial of Perillyl Alcohol in Breast Neoplasia
Vered Stearns(University of Michigan), Matthew J. Ellis(Washington University in St. Louis), Ann Gallagher, Baljit Singh(University of Saskatchewan), Daniel F. Hayes(University of Michigan), Andrew Coop, Hideko Yamauchi, Bruce J. Trock(Johns Hopkins University), Ronald Lieberman(National Cancer Institute), Marie Pennanen(Icahn School of Medicine at Mount Sinai)
Cited by 20
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k